#digitaltransformation #newtechnology

New technologies shift consumer expectations, challenge norms, and put pressure on organizations to respond. Digital transformation is more critical now than ever. It is the holistic process by which an organization redefines and betters itself using the digital technologies which metamorphosize business and society at large. The biggest shift is to embrace digital completely and redefine the customer experience as a whole. Businesses today face a digital catch-22. Unless they succeed at digital transformation, they will become irrelevant. But digital transformation is costly, difficult and the required investment may be more urgently needed elsewhere in the short-term.



The coronavirus pandemic has accelerated the move to digital transformation as organisations responded to the need for staff to work from home, but as wider DX projects move into a higher gear, organisations should look to past failures to avoid making the same mistakes. The opportunity of DX lies in the fact that digital technology can now be applied to almost every aspect of business to enable greater speed and efficiency, but business leaders typically struggle to understand which opportunities to pursue and prioritise. In this hyper competitive market, medical technology companies are focusing heavily into accelerated product development while partnering with the best PaaS provider to help realize their overall digital transformation goals. Pharma 4.0 concepts are taking hold in pharmaceutical manufacturing. The industry's unique characteristics are driving investments in digital transformation by pharmaceutical manufacturers. A report states, digital factory revenue will top 4.5 billion dollars in 2030 with spending by pharmaceutical manufacturers on data analytics forecast to grow by a 27% CAGR and be worth 1.2 billion dollars in 2030, as manufacturers look to track, optimize their operations, and boost productivity.
<.